Boots to Health Foundation

For decades, the standard treatment for veteran PTSD has looked roughly the same: talk therapy, SSRIs, and a referral back to the same system that too often left veterans feeling unheard. Millions of veterans have cycled through those options and still found themselves stuck — unable to sleep, unable to connect, unable to quiet the noise.

Now, a growing body of research — and a landmark VA study — is pointing toward something different. Psychedelic-assisted therapy, once the fringe of medicine, is becoming one of the most discussed topics in veteran health. And veterans aren’t waiting to lead the conversation.

What Just Happened With the VA and Psilocybin

In late 2024, the Department of Veterans Affairs launched a major clinical study examining the effectiveness of psilocybin — the active compound in so-called “magic mushrooms” — on major depressive disorder and PTSD in veterans. This is significant. The VA is one of the most conservative medical institutions in the country, and when it moves toward psychedelic research, it signals that the evidence has become too compelling to ignore.

This comes on the heels of years of independent research out of institutions like Johns Hopkins University and NYU, where psilocybin trials showed remarkable results for depression and anxiety — often after just one or two guided sessions. Some participants described the experience as one of the most meaningful of their lives, reporting lasting improvements in mood, reduced PTSD symptoms, and a renewed sense of purpose.

Why Veterans Are Leading This Conversation

Veterans have never been passive about their healthcare. From the Agent Orange fight to the PACT Act, they’ve consistently pushed the system forward when the system wasn’t moving fast enough. Psychedelic therapy is no different.

Organizations like Veterans Exploring Treatment Solutions (VETS) have been funding and advocating for psychedelic research specifically for veterans since 2019 — long before the mainstream caught up. Thousands of veterans have already sought out psilocybin or MDMA-assisted therapy through clinical trials, legal retreats in countries like Jamaica and the Netherlands, or — in states like Oregon and Colorado — through regulated therapeutic programs.

Why are veterans so drawn to this? Several reasons:

• Traditional treatments have failed too many of them. SSRIs work for some people, but for veterans with complex, combat-related trauma, the response rates are often low. The status quo has a 22-veteran-a-day suicide problem. That’s not acceptable.
• The experience aligns with how veterans already think. Psychedelic therapy isn’t passive. It requires courage, preparation, and willingness to face difficult things head-on — values that resonate deeply in military culture.
• The results are hard to argue with. When fellow veterans come back from sessions describing genuine relief after years of suffering, word travels fast in tight-knit veteran communities.

What Does the Research Actually Show?

It’s important to separate hype from evidence — and the evidence is genuinely promising, with appropriate caveats.

Psilocybin: Multiple Phase 2 clinical trials have shown significant reductions in depression and PTSD symptoms after psilocybin-assisted therapy. A landmark Johns Hopkins study found that two sessions of psilocybin-assisted therapy produced rapid, substantial, and sustained decreases in depressive symptoms in 71% of participants — effects that persisted at the 12-month follow-up. While most trials have not focused exclusively on veterans, veteran-specific trials are now underway.

MDMA-assisted therapy: MAPS (the Multidisciplinary Association for Psychedelic Studies) completed Phase 3 trials of MDMA-assisted therapy for PTSD, with results showing that 67% of participants no longer met the diagnostic criteria for PTSD after treatment, compared to 32% in the placebo group. The FDA rejected the initial application in 2024 citing data concerns, but the research continues and many experts expect eventual approval.

Important note: These therapies are conducted in carefully controlled, therapeutic settings with trained guides. They are not recreational use. The substance itself is one part of a larger therapeutic process that includes preparation sessions, the guided experience, and integration work afterward.

What’s Legal Right Now?

This is where many veterans get understandably frustrated — the research shows promise, but access is still limited.

• Oregon and Colorado have established regulated psilocybin service centers where adults can access supervised psilocybin sessions. More states are expected to follow.
• Clinical trials are actively enrolling veteran participants. The VA study, as well as several university-based trials, offer a legal, structured path to access.
• Ketamine therapy, which operates similarly in terms of its dissociative and anti-depressant effects, is already FDA-approved and widely available at certified clinics. Many veterans use ketamine-assisted therapy as a legal, accessible bridge while broader psychedelic access expands.
• Outside the U.S., legal retreat programs operate in Jamaica, the Netherlands, and other countries. VETS has helped fund veteran access to some of these programs.

This Isn’t a Magic Bullet — But It Might Be a Door

We want to be honest: psychedelic therapy is not a cure-all, and it’s not right for everyone. Veterans with certain mental health conditions, medications, or personal histories may not be candidates. Anyone exploring this path should do so in consultation with a knowledgeable healthcare provider, not alone.

But here’s what this moment represents: the beginning of a real expansion in what’s possible for veteran mental health care. For veterans who have tried everything else and still haven’t found relief, that expansion matters enormously.

At Boots to Health Foundation, we’re committed to staying at the forefront of what the veteran health community is talking about — because that’s how we serve veterans well. We don’t just offer what’s conventional. We pay attention to what’s working, what’s emerging, and what our veterans deserve access to.

Resources to Explore

• VETS (Veterans Exploring Treatment Solutions) — vetsolutions.org — connects veterans with psychedelic therapy research and funding opportunities
• MAPS — maps.org — leading MDMA-assisted therapy research
• ClinicalTrials.gov — search “psilocybin veterans” or “MDMA PTSD” to find currently enrolling trials
• Veterans Crisis Line — Call or text 988, then press 1. If you’re in crisis right now, please reach out.

If you’re a veteran navigating mental health challenges and want to talk about what support is available through Boots to Health Foundation, reach out to us here. You don’t have to figure this out alone.